Home
>
National Drug Code (NDC)
>
Pulmozyme
Pulmozyme - 50242-100-40 - (dornase alfa)
Drug Information of Pulmozyme
| Product NDC: | 50242-100 |
| Proprietary Name: | Pulmozyme |
| Non Proprietary Name: | dornase alfa |
| Active Ingredient(s): | 1 mg/mL & nbsp; dornase alfa |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pulmozyme
| Product NDC: | 50242-100 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103532 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19931230 |
Package Information of Pulmozyme
| Package NDC: | 50242-100-40 |
| Package Description: | 5 POUCH in 1 CARTON (50242-100-40) > 6 AMPULE in 1 POUCH > 2.5 mL in 1 AMPULE |
NDC Information of Pulmozyme
| NDC Code | 50242-100-40 |
| Proprietary Name | Pulmozyme |
| Package Description | 5 POUCH in 1 CARTON (50242-100-40) > 6 AMPULE in 1 POUCH > 2.5 mL in 1 AMPULE |
| Product NDC | 50242-100 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dornase alfa |
| Dosage Form Name | SOLUTION |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 19931230 |
| Marketing Category Name | BLA |
| Labeler Name | Genentech, Inc. |
| Substance Name | DORNASE ALFA |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Respiratory Secretion Viscosity [PE],Deoxyribonuclease I [Chemical/Ingredient],Recombinant Human Deoxyribonuclease 1 [EPC],Recombinant Proteins [Chemical/Ingredient] |
